Detalhe da pesquisa
1.
Activated STING in a vascular and pulmonary syndrome.
N Engl J Med;
371(6): 507-518, 2014 08 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25029335
2.
Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
Cancer Res;
52(7): 1830-5, 1992 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-1312901
3.
Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin.
J Clin Oncol;
5(12): 1900-11, 1987 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-3500279
4.
Specific expression of insulin-like growth factor-II in rhabdomyosarcoma tumor cells.
Am J Clin Pathol;
101(2): 198-203, 1994 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-8116575
5.
Children's National Medical Center's transfusion protocol for sickle hemoglobinopathies.
Immunohematology;
22(3): 117-20, 2006.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17105359
6.
IGF-II in the pathogenesis of rhabdomyosarcoma: a prototype of IGFs involvement in human tumorigenesis.
Adv Exp Med Biol;
343: 327-43, 1993.
Artigo
em Inglês
| MEDLINE
| ID: mdl-7514344
7.
Cranial irradiation and platelet monoamine oxidase in ALL.
Acta Haematol;
73(2): 86-8, 1985.
Artigo
em Inglês
| MEDLINE
| ID: mdl-3925692
8.
Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotype.
Cell Growth Differ;
6(3): 263-9, 1995 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-7794794
9.
The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells.
J Biol Chem;
267(13): 9000-4, 1992 May 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-1315746